Skip to main content
. 2012 Jan;19(1):30–36. doi: 10.1128/CVI.05466-11

Fig 5.

Fig 5

Reactivity of human sera against recombinant SalI and DEKnull. A pool of high-titer anti-DBPII inhibitory human serum from PNG was affinity purified and tested by endpoint dilution for reactivity with recombinant SalI and DEKnull. Recombinant SalI or DEKnull was adsorbed onto wells of the microtiter plate and probed with tripling dilutions of either affinity-purified anti-SalI or anti-DEKnull. Each point on the curves represents the mean OD values of each dilution tested in triplicate.